Debt-to-equity of Fulgent Genetics, Inc. from 30 Jun 2017 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Fulgent Genetics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2017 to 31 Dec 2025.
  • Fulgent Genetics, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 8.3%, a 5.1% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Fulgent Genetics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 8.3% -0.44% -5.1% 31 Dec 2025
Q3 2025 7.9% -1.1% -12% 30 Sep 2025
Q2 2025 8% -0.71% -8.2% 30 Jun 2025
Q1 2025 8.3% +0.08% +1% 31 Mar 2025
Q4 2024 8.7% +0.66% +8.1% 31 Dec 2024
Q3 2024 9% +0.83% +10% 30 Sep 2024
Q2 2024 8.7% +0.03% +0.3% 30 Jun 2024
Q1 2024 8.2% -1.6% -16% 31 Mar 2024
Q4 2023 8.1% -2.5% -23% 31 Dec 2023
Q3 2023 8.2% -2.6% -24% 30 Sep 2023
Q2 2023 8.7% -3.3% -28% 30 Jun 2023
Q1 2023 9.8% -2.8% -22% 31 Mar 2023
Q4 2022 11% -4.8% -31% 31 Dec 2022
Q3 2022 11% -7.9% -42% 30 Sep 2022
Q2 2022 12% -9% -43% 30 Jun 2022
Q1 2022 13% -12% -48% 31 Mar 2022
Q4 2021 15% -7.2% -32% 31 Dec 2021
Q3 2021 19% -0.37% -1.9% 30 Sep 2021
Q2 2021 21% +11% +118% 30 Jun 2021
Q1 2021 24% +15% +152% 31 Mar 2021
Q4 2020 23% +13% +128% 31 Dec 2020
Q3 2020 19% +9.1% +93% 30 Sep 2020
Q2 2020 9.6% +1.8% +23% 30 Jun 2020
Q1 2020 9.6% +2.9% +44% 31 Mar 2020
Q4 2019 9.9% +4.9% +99% 31 Dec 2019
Q3 2019 9.8% +4.8% +96% 30 Sep 2019
Q2 2019 7.8% +2.3% +42% 30 Jun 2019
Q1 2019 6.6% +1.2% +22% 31 Mar 2019
Q4 2018 5% -0.92% -16% 31 Dec 2018
Q3 2018 5% -1.1% -18% 30 Sep 2018
Q2 2018 5.5% -3.1% -36% 30 Jun 2018
Q1 2018 5.4% 31 Mar 2018
Q4 2017 5.9% 31 Dec 2017
Q3 2017 6.1% 30 Sep 2017
Q2 2017 8.6% 30 Jun 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.